GLAUKOS Corp Cash and Restricted Cash
GLAUKOS Corp (GKOS) had Cash and Restricted Cash of $117.60 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $117.60M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108.08M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94.65M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $102.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $117.60M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $108.08M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $94.65M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $102.08M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $104.65M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $118.98M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $174.36M 10-Q · filed 2026-07-29 |
| 2024-09-30 | $104.88M 10-Q · filed 2025-10-31 |
| 2024-06-30 | $72.81M 10-Q · filed 2025-08-04 |
| 2024-03-31 | $48.35M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $99.32M 10-K · filed 2026-02-23 |
| 2023-09-30 | $114.78M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $100.67M 10-Q · filed 2024-08-02 |
| 2023-03-31 | $83.48M 10-Q · filed 2024-05-03 |
| 2022-12-31 | $126.60M 10-K · filed 2026-02-23 |
| 2022-09-30 | $113.10M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $111.68M 10-Q · filed 2023-08-02 |
| 2022-03-31 | $115.62M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $110.12M 10-K · filed 2025-02-25 |
| 2021-09-30 | $122.55M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $127.71M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $106.04M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $106.16M 10-K · filed 2024-02-23 |
| 2020-09-30 | $90.32M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $276.30M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $62.94M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $71.76M 10-K · filed 2023-02-24 |
| 2019-09-30 | $48.41M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $48.84M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $42.49M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $38.60M 10-K · filed 2022-02-28 |
| 2018-09-30 | $37.28M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $24.94M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $15.59M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $24.51M 10-K · filed 2021-03-01 |
| 2017-09-30 | $19.32M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $13.37M 10-Q · filed 2018-08-06 |
| 2017-03-31 | $8.65M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $6.57M 10-K · filed 2020-03-02 |
| 2015-12-31 | $21.65M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |